Article
APOE 4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB…
Current research in translational medicine · 2022 · L. Abdullah, Z. Arvanitakis, DA. Bennett, F. Crawford, A. Cseresznye, T. Darcey, JE. Evans, CJC. Huguenard, AP. Keegan, C. Luis, M. Mullan, A. Nkiliza, HN. Yassine
Key facts
| Title | APOE 4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain. |
|---|---|
| First author | L. Abdullah, Z. Arvanitakis, DA. Bennett, F. Crawford, A. Cseresznye, T. Darcey, JE. Evans, CJC. Huguenard, AP. Keegan, C. Luis, M. Mullan, A. Nkiliza, HN. Yassine |
| Journal | Current research in translational medicine |
| Published | Aug 11, 2022 |
| DOI | 10.1016/j.retram.2022.103362 |
| PubMed ID | 36436355 |
| PMC ID | PMC10066735 |
| Devices mentioned | 103362 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1